Clinical interventions to reduce secondhand smoke exposure among pregnant women: a systematic review.
Clinical interventions to reduce secondhand smoke exposure among pregnant women: a systematic review.
复制标题
DOI：
10.1136/tobaccocontrol-2013-051200
复制
发表时间：
2015-05
期刊：
影响因子：
5.2
通讯作者：
England LJ
中科院分区：
文献类型：
--
作者：
Tong VT;Dietz PM;Rolle IV;Kennedy SM;Thomas W;England LJ
对减少非吸烟孕妇二手烟（SHS）暴露的临床干预措施进行系统评价。我们检索了 16 个数据库，查找 1990 年至 2013 年 1 月期间的出版物，没有语言限制。如果论文符合以下标准，则被纳入：（1）研究人群包括暴露于二手烟的非吸烟孕妇，（2）临床干预措施旨在减少家庭二手烟暴露，（3）研究包括对照组，（4）结果包括减少不吸烟孕妇在家中二手烟暴露或女性怀孕期间吸烟伴侣的戒烟率。两名编码员独立审查每个摘要或全文，以确定合格的论文。两名摘要者根据美国预防服务工作组的研究质量标准（良好、一般、差）独立编码论文，未经生化验证结果测量的研究被认为质量较差。从 4670 篇论文中，我们确定了 5 项符合纳入标准的研究：其中四项重点关注减少不吸烟孕妇的二手烟暴露，一项重点关注为孕妇的吸烟伴侣提供戒烟支持。所有试验都是随机对照试验，并且都报告了积极的结果。三项研究被认为质量较差，因为结果测量未经生化验证，而两项研究被认为质量一般。在产前护理机构中提供的临床干预措施似乎可以减少二手烟暴露，但研究的缺陷限制了我们得出明确结论的能力。需要使用生化验证进行更严格的研究，以确定减少孕妇接触二手烟的策略。
To conduct a systematic review of clinical interventions to reduce secondhand smoke (SHS) exposure among non-smoking pregnant women. We searched 16 databases for publications from 1990 to January 2013, with no language restrictions. Papers were included if they met the following criteria: (1) the study population included non-smoking pregnant women exposed to SHS, (2) the clinical interventions were intended to reduce SHS exposure at home, (3) the study included a control group and (4) outcomes included either reduced SHS exposure of non-smoking pregnant women at home or quit rates among smoking partners during the pregnancy of the woman. Two coders independently reviewed each abstract or full text to identify eligible papers. Two abstractors independently coded papers based on US Preventive Services Task Force criteria for study quality (good, fair, poor), and studies without biochemically-verified outcome measures were considered poor quality. From 4670 papers, we identified five studies that met our inclusion criteria: four focused on reducing SHS exposure among non-smoking pregnant women, and one focused on providing cessation support for smoking partners of pregnant women. All were randomised controlled trials, and all reported positive findings. Three studies were judged poor quality because outcome measures were not biochemically-verified, and two were considered fair quality. Clinical interventions delivered in prenatal care settings appear to reduce SHS exposure, but study weaknesses limit our ability to draw firm conclusions. More rigorous studies, using biochemical validation, are needed to identify strategies for reducing SHS exposure in pregnant women.